Widespread recall of chlorthalidone BP tablets over dissolution issue

More than 11,000 bottles of the blood pressure medication Chlorthalidone Tablets USP, 25 mg, were recalled nationwide after a manufacturing issue caused dissolution failures. The recall involves both 100-count and 1,000-count bottles distributed in the United States by Rising Pharma Holdings Inc. of New Jersey; 11,460 bottles are included. Inventia Healthcare Limited initiated the voluntary recall on June 5. The FDA enforcement report notes the tablets may not dissolve as intended, and patients should consult their pharmacist or healthcare provider if they may have a recalled bottle; do not stop taking prescribed medication without medical advice.